{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:50:22Z","timestamp":1780105822182,"version":"3.54.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.ijcard.2005.05.055","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T14:03:38Z","timestamp":1120745018000},"page":"48-52","source":"Crossref","is-referenced-by-count":30,"title":["The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level"],"prefix":"10.1016","volume":"109","author":[{"given":"Dimitris","family":"Tousoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Antoniades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Katsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erini","family":"Bosinakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kotsopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos","family":"Stefanadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2005.05.055_bib1","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.05.055_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol level","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.05.055_bib3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.05.055_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.05.055_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.05.055_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-8703(00)90033-4","article-title":"Statins: effective antiatherosclerotic therapy","volume":"139","author":"Blumenthal","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2005.05.055_bib7","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (reduction of cholesterol in ischemia and function of endothelium) trial","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.05.055_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(95)91322-X","article-title":"Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication","volume":"346","author":"Stroes","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.05.055_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.05.055_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.bmb.a072928","article-title":"Lipids\u2013thrombosis interface","volume":"50","author":"Mitropoulos","year":"1994","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ijcard.2005.05.055_bib11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin","volume":"353","author":"Rosnenson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.05.055_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(00)00870-0","article-title":"Pravastatin down-regulates inflammatory mediators in human monocytes in vitro","volume":"410","author":"Grip","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijcard.2005.05.055_bib13","first-page":"183","article-title":"Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide","volume":"48","author":"Romano","year":"2000","journal-title":"J Investig Med"},{"key":"10.1016\/j.ijcard.2005.05.055_bib14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","volume":"36","author":"Braunwald","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.05.055_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0008-6363(00)00146-2","article-title":"Effects of statins on vascular wall: vasomotor function, inflammation and plaque stability","volume":"47","author":"Koh","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2005.05.055_bib16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.103.9.1191","article-title":"Rapid reduction of C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolaemia","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.05.055_bib17","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijcard.2005.05.055_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.amjcard.2003.11.017","article-title":"Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris","volume":"93","author":"Doo","year":"2004","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.ijcard.2005.05.055_bib19","first-page":"II","article-title":"Early statin use in acute myocardial infarction is associated with a reduced hospital mortality: results of Mitra-2","volume":"102","author":"Schiele","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.05.055_bib20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2005.05.055_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0002-9149(03)00630-1","article-title":"Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction","volume":"92","author":"Correia","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2005.05.055_bib22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(00)04257-4","article-title":"Effect of lipid lowering therapy on early mortality after acute coronary syndromes: an observational study","volume":"357","author":"Aronow","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.05.055_bib23","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1001\/jama.287.23.3087","article-title":"Sibrafiban vs aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes. Early statin initiation and outcomes in patients with acute coronary syndromes","volume":"287","author":"Newby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2005.05.055_bib24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.05.055_bib25","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.CIR.0000091404.09558.AF","article-title":"High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study","volume":"108","author":"Kinlay","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.05.055_bib26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes.The MIRACL study","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2005.05.055_bib27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2005.05.055_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering\u2014are they clinically relevant?","volume":"24","author":"Bonetti","year":"2003","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ijcard.2005.05.055_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/jpet.102.034959","article-title":"Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1","volume":"302","author":"Li","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.ijcard.2005.05.055_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9150(99)00193-8","article-title":"Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells","volume":"147","author":"Ortego","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2005.05.055_bib31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jlb.55.6.749","article-title":"Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells","volume":"55","author":"Terkeltaub","year":"1994","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ijcard.2005.05.055_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lab.2004.11.012","article-title":"Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects","volume":"145","author":"Rosenson","year":"2005","journal-title":"J Lab Clin Med"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527305007904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527305007904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T17:02:54Z","timestamp":1551805374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527305007904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0167527305007904"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2005.05.055","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}